Related Experiment Video
Updated: Dec 14, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion
Amira Assaf1, Roberto Diletti1, Mark G Hoogendijk1
1Department of Cardiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam, The Netherlands.
Insights
Chronic total occlusion (CTO) increases ventricular arrhythmia risk and may predict implantable cardioverter-defibrillator (ICD) therapy. Revascularization may improve electrical stability, warranting further research into its anti-arrhythmic effects.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Chronic total occlusion (CTO) is linked to a higher risk of ventricular arrhythmias.
- CTO presence predicts the need for appropriate implantable cardioverter-defibrillator (ICD) therapy.
Purpose of the Study:
- To review the association between CTO and ventricular arrhythmias.
- To explore arrhythmogenic mechanisms and the impact of revascularization on ventricular arrhythmias.
Main Methods:
- Literature review on CTO and ventricular arrhythmias.
- Analysis of arrhythmogenic mechanisms in CTO territories.
- Evaluation of revascularization effects on electrical properties.
Main Results:
- CTO creates a pro-arrhythmogenic environment with scar, ischemia, and electrical heterogeneity.
- Revascularization may lead to electrical homogenization, reducing QT dispersion and late potentials.
- CTO is an independent predictor of appropriate ICD therapy.
Conclusions:
- CTO is a significant risk factor for ventricular arrhythmias and ICD therapy.
- Revascularization may mitigate arrhythmia risk through electrical homogenization.
- Further research is needed to confirm revascularization benefits and identify ICD candidates using risk stratification tools.
Introduction:
The presence of a chronic total occlusion (CTO) is associated with an increased risk of ventricular arrhythmias.
Areas Covered:
This review provides an overview of the relationship between CTO and ventricular arrhythmias, arrhythmogenic mechanisms, and the effect of revascularization.
Expert Opinion:
Studies in recipients of an implantable cardioverter-defibrillator (ICD) have shown that a CTO is an independent predictor of appropriate ICD therapy. The myocardial territory supplied by a CTO is a pro-arrhythmogenic milieu characterized by scar tissue, large scar border zone, hibernating myocardium, residual ischemia despite collaterals, areas of slow conduction, and heterogeneity in repolarization. Restoring coronary flow by revascularization might be associated with electrical homogenization as reflected by a decrease in QT(c) dispersion, decrease in T wave peak-to-end interval, reduction of late potentials, and decrease in scar border zone area. Future research should explore whether CTO revascularization results in a lower burden of ventricular arrhythmias. Furthermore, risk stratification of CTO patients without severe LV dysfunction is interesting to identify potential ICD candidates. Potential tools for risk stratification are the use of electrocardiographic parameters, body surface mapping, electrophysiological study, and close rhythm monitoring using an insertable cardiac monitor.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease I: Introduction